NewGLAB Pharma CO.,LTD 214870.KQ Stock
NewGLAB Pharma CO.,LTD Price Chart
NewGLAB Pharma CO.,LTD 214870.KQ Financial and Trading Overview
NewGLAB Pharma CO.,LTD stock price | 1383 KRW |
Previous Close | 1383 KRW |
Open | 0 KRW |
Bid | 0 KRW x N/A |
Ask | 0 KRW x N/A |
Day's Range | 1383 - 1383 KRW |
52 Week Range | 1383 - 1383 KRW |
Volume | 0 KRW |
Avg. Volume | N/A |
Market Cap | 26.89B KRW |
Beta (5Y Monthly) | 0.341859 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
214870.KQ Valuation Measures
Enterprise Value | 166.02B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.0118513 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 6.246 |
Enterprise Value/EBITDA | -7.303 |
Trading Information
NewGLAB Pharma CO.,LTD Stock Price History
Beta (5Y Monthly) | 0.341859 |
52-Week Change | N/A |
S&P500 52-Week Change | 20.43% |
52 Week High | 1383 KRW |
52 Week Low | 1383 KRW |
50-Day Moving Average | N/A |
200-Day Moving Average | N/A |
214870.KQ Share Statistics
Avg. Volume (3 month) | N/A |
Avg. Daily Volume (10-Days) | N/A |
Shares Outstanding | 19.45M |
Float | 26.26M |
Short Ratio | N/A |
% Held by Insiders | 9.03% |
% Held by Institutions | 0.051% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | -172.69% |
Operating Margin (ttm) | -102.59% |
Gross Margin | 17.26% |
EBITDA Margin | -85.53% |
Management Effectiveness
Return on Assets (ttm) | -15.31% |
Return on Equity (ttm) | -126.062% |
Income Statement
Revenue (ttm) | 26.58B KRW |
Revenue Per Share (ttm) | 850.63 KRW |
Quarterly Revenue Growth (yoy) | 14.29% |
Gross Profit (ttm) | 3.35B KRW |
EBITDA | -22734624768 KRW |
Net Income Avi to Common (ttm) | -45900877824 KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 15.79B KRW |
Total Cash Per Share (mrq) | 490.14 KRW |
Total Debt (mrq) | 47.12B KRW |
Total Debt/Equity (mrq) | 237.82 KRW |
Current Ratio (mrq) | 0.704 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 14.21B KRW |
Levered Free Cash Flow (ttm) | 40.12B KRW |
Profile of NewGLAB Pharma CO.,LTD
Country | South Korea |
State | N/A |
City | Bucheon-Si |
Address | HDPro Building |
ZIP | N/A |
Phone | 82 3 2683 7903 |
Website | https://newglab.com |
Industry | |
Sector(s) | |
Full Time Employees | 23 |
NewGLAB Pharma CO.,LTD provides CCTV video security solutions in South Korea and internationally. The company offers network cameras, analog cameras, and ACCs under the HDPRO name, as well as technical support services. It also provides VR solutions; and distributes 5G smart phone accessories and daily supplies, including wireless earphones and vacuum cleaners, ninebots, and toothbrush sterilizers. The company was formerly known as NewGLAB CO.,LTD and changed its name to NewGLAB Pharma CO.,LTD. NewGLAB Pharma CO.,LTD was founded in 2004 and is headquartered in Bucheon, South Korea.
Q&A For NewGLAB Pharma CO.,LTD Stock
What is a current 214870.KQ stock price?
NewGLAB Pharma CO.,LTD 214870.KQ stock price today per share is 1383 KRW.
How to purchase NewGLAB Pharma CO.,LTD stock?
You can buy 214870.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NewGLAB Pharma CO.,LTD?
The stock symbol or ticker of NewGLAB Pharma CO.,LTD is 214870.KQ.
How many shares does NewGLAB Pharma CO.,LTD have in circulation?
The max supply of NewGLAB Pharma CO.,LTD shares is 19.45M.
What is NewGLAB Pharma CO.,LTD Price to Earnings Ratio (PE Ratio)?
NewGLAB Pharma CO.,LTD PE Ratio is now.
What was NewGLAB Pharma CO.,LTD earnings per share over the trailing 12 months (TTM)?
NewGLAB Pharma CO.,LTD EPS is 0 KRW over the trailing 12 months.